Canada's National Advisory Committee on Immunization is expected to recommend today a pause in the use of the AstraZeneca-Oxford COVID-19 vaccine on those under the age of 55 because of safety concerns, sources tell CBC News.
Canada's National Advisory Committee on Immunization is expected to recommend today a pause in the use of the AstraZeneca-Oxford COVID-19 vaccine on those under the age of 55 because of safety concerns, sources tell CBC News.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.